Global Autoimmune Drugs Market Insights, Forecast to 2029

Global Autoimmune Drugs Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Autoimmune Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Autoimmune Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Rheumatoid Arthritis (RA)
1.2.3 Multiple Sclerosis (MS)
1.2.4 Psoriasis
1.2.5 Inflammatory Bowel Disease (IBD)
1.2.6 Ankylosing Spondylitis (AS)
1.2.7 Systemic Lupus Erythematosus (SLE)
1.3 Market by Application
1.3.1 Global Autoimmune Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Autoimmune Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Autoimmune Drugs Revenue by Region
2.2.1 Global Autoimmune Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Autoimmune Drugs Revenue by Region (2018-2023)
2.2.3 Global Autoimmune Drugs Revenue by Region (2024-2029)
2.2.4 Global Autoimmune Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Autoimmune Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Autoimmune Drugs Sales by Region
2.4.1 Global Autoimmune Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Autoimmune Drugs Sales by Region (2018-2023)
2.4.3 Global Autoimmune Drugs Sales by Region (2024-2029)
2.4.4 Global Autoimmune Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Autoimmune Drugs Sales by Manufacturers
3.1.1 Global Autoimmune Drugs Sales by Manufacturers (2018-2023)
3.1.2 Global Autoimmune Drugs Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Autoimmune Drugs in 2022
3.2 Global Autoimmune Drugs Revenue by Manufacturers
3.2.1 Global Autoimmune Drugs Revenue by Manufacturers (2018-2023)
3.2.2 Global Autoimmune Drugs Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Autoimmune Drugs Revenue in 2022
3.3 Global Key Players of Autoimmune Drugs, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Autoimmune Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Autoimmune Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Autoimmune Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Autoimmune Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Autoimmune Drugs Sales by Type
4.1.1 Global Autoimmune Drugs Historical Sales by Type (2018-2023)
4.1.2 Global Autoimmune Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Autoimmune Drugs Sales Market Share by Type (2018-2029)
4.2 Global Autoimmune Drugs Revenue by Type
4.2.1 Global Autoimmune Drugs Historical Revenue by Type (2018-2023)
4.2.2 Global Autoimmune Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Autoimmune Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Autoimmune Drugs Price by Type
4.3.1 Global Autoimmune Drugs Price by Type (2018-2023)
4.3.2 Global Autoimmune Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Autoimmune Drugs Sales by Application
5.1.1 Global Autoimmune Drugs Historical Sales by Application (2018-2023)
5.1.2 Global Autoimmune Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Autoimmune Drugs Sales Market Share by Application (2018-2029)
5.2 Global Autoimmune Drugs Revenue by Application
5.2.1 Global Autoimmune Drugs Historical Revenue by Application (2018-2023)
5.2.2 Global Autoimmune Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Autoimmune Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Autoimmune Drugs Price by Application
5.3.1 Global Autoimmune Drugs Price by Application (2018-2023)
5.3.2 Global Autoimmune Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Autoimmune Drugs Market Size by Type
6.1.1 US & Canada Autoimmune Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Autoimmune Drugs Revenue by Type (2018-2029)
6.2 US & Canada Autoimmune Drugs Market Size by Application
6.2.1 US & Canada Autoimmune Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Autoimmune Drugs Revenue by Application (2018-2029)
6.3 US & Canada Autoimmune Drugs Market Size by Country
6.3.1 US & Canada Autoimmune Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Autoimmune Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Autoimmune Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Autoimmune Drugs Market Size by Type
7.1.1 Europe Autoimmune Drugs Sales by Type (2018-2029)
7.1.2 Europe Autoimmune Drugs Revenue by Type (2018-2029)
7.2 Europe Autoimmune Drugs Market Size by Application
7.2.1 Europe Autoimmune Drugs Sales by Application (2018-2029)
7.2.2 Europe Autoimmune Drugs Revenue by Application (2018-2029)
7.3 Europe Autoimmune Drugs Market Size by Country
7.3.1 Europe Autoimmune Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Autoimmune Drugs Sales by Country (2018-2029)
7.3.3 Europe Autoimmune Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Autoimmune Drugs Market Size
8.1.1 China Autoimmune Drugs Sales (2018-2029)
8.1.2 China Autoimmune Drugs Revenue (2018-2029)
8.2 China Autoimmune Drugs Market Size by Application
8.2.1 China Autoimmune Drugs Sales by Application (2018-2029)
8.2.2 China Autoimmune Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Autoimmune Drugs Market Size by Type
9.1.1 Asia Autoimmune Drugs Sales by Type (2018-2029)
9.1.2 Asia Autoimmune Drugs Revenue by Type (2018-2029)
9.2 Asia Autoimmune Drugs Market Size by Application
9.2.1 Asia Autoimmune Drugs Sales by Application (2018-2029)
9.2.2 Asia Autoimmune Drugs Revenue by Application (2018-2029)
9.3 Asia Autoimmune Drugs Sales by Region
9.3.1 Asia Autoimmune Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Autoimmune Drugs Revenue by Region (2018-2029)
9.3.3 Asia Autoimmune Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Autoimmune Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Autoimmune Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Autoimmune Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Autoimmune Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Autoimmune Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Autoimmune Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Autoimmune Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Autoimmune Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Autoimmune Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Autoimmune Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Eli Lilly Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 GSK Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Overview
11.3.3 AbbVie Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 AbbVie Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AbbVie Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Johnson & Johnson Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Biogen
11.5.1 Biogen Company Information
11.5.2 Biogen Overview
11.5.3 Biogen Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Biogen Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biogen Recent Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Overview
11.6.3 Amgen Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Amgen Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Amgen Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Pfizer Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Overview
11.8.3 Roche Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Roche Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Roche Recent Developments
11.9 Baxter
11.9.1 Baxter Company Information
11.9.2 Baxter Overview
11.9.3 Baxter Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Baxter Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Baxter Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Autoimmune Drugs Industry Chain Analysis
12.2 Autoimmune Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Autoimmune Drugs Production Mode & Process
12.4 Autoimmune Drugs Sales and Marketing
12.4.1 Autoimmune Drugs Sales Channels
12.4.2 Autoimmune Drugs Distributors
12.5 Autoimmune Drugs Customers
13 Market Dynamics
13.1 Autoimmune Drugs Industry Trends
13.2 Autoimmune Drugs Market Drivers
13.3 Autoimmune Drugs Market Challenges
13.4 Autoimmune Drugs Market Restraints
14 Key Findings in The Global Autoimmune Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Autoimmune Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Rheumatoid Arthritis (RA)
Table 3. Major Manufacturers of Multiple Sclerosis (MS)
Table 4. Major Manufacturers of Psoriasis
Table 5. Major Manufacturers of Inflammatory Bowel Disease (IBD)
Table 6. Major Manufacturers of Ankylosing Spondylitis (AS)
Table 7. Major Manufacturers of Systemic Lupus Erythematosus (SLE)
Table 8. Global Autoimmune Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Autoimmune Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Autoimmune Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Autoimmune Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Autoimmune Drugs Revenue Market Share by Region (2018-2023)
Table 13. Global Autoimmune Drugs Revenue Market Share by Region (2024-2029)
Table 14. Global Autoimmune Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Autoimmune Drugs Sales by Region (2018-2023) & (K Units)
Table 16. Global Autoimmune Drugs Sales by Region (2024-2029) & (K Units)
Table 17. Global Autoimmune Drugs Sales Market Share by Region (2018-2023)
Table 18. Global Autoimmune Drugs Sales Market Share by Region (2024-2029)
Table 19. Global Autoimmune Drugs Sales by Manufacturers (2018-2023) & (K Units)
Table 20. Global Autoimmune Drugs Sales Share by Manufacturers (2018-2023)
Table 21. Global Autoimmune Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Autoimmune Drugs Revenue Share by Manufacturers (2018-2023)
Table 23. Global Key Players of Autoimmune Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 24. Autoimmune Drugs Price by Manufacturers 2018-2023 (USD/Unit)
Table 25. Global Autoimmune Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Autoimmune Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Drugs as of 2022)
Table 27. Global Key Manufacturers of Autoimmune Drugs, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Autoimmune Drugs, Product Offered and Application
Table 29. Global Key Manufacturers of Autoimmune Drugs, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Autoimmune Drugs Sales by Type (2018-2023) & (K Units)
Table 32. Global Autoimmune Drugs Sales by Type (2024-2029) & (K Units)
Table 33. Global Autoimmune Drugs Sales Share by Type (2018-2023)
Table 34. Global Autoimmune Drugs Sales Share by Type (2024-2029)
Table 35. Global Autoimmune Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Autoimmune Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Autoimmune Drugs Revenue Share by Type (2018-2023)
Table 38. Global Autoimmune Drugs Revenue Share by Type (2024-2029)
Table 39. Autoimmune Drugs Price by Type (2018-2023) & (USD/Unit)
Table 40. Global Autoimmune Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 41. Global Autoimmune Drugs Sales by Application (2018-2023) & (K Units)
Table 42. Global Autoimmune Drugs Sales by Application (2024-2029) & (K Units)
Table 43. Global Autoimmune Drugs Sales Share by Application (2018-2023)
Table 44. Global Autoimmune Drugs Sales Share by Application (2024-2029)
Table 45. Global Autoimmune Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Autoimmune Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Autoimmune Drugs Revenue Share by Application (2018-2023)
Table 48. Global Autoimmune Drugs Revenue Share by Application (2024-2029)
Table 49. Autoimmune Drugs Price by Application (2018-2023) & (USD/Unit)
Table 50. Global Autoimmune Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 51. US & Canada Autoimmune Drugs Sales by Type (2018-2023) & (K Units)
Table 52. US & Canada Autoimmune Drugs Sales by Type (2024-2029) & (K Units)
Table 53. US & Canada Autoimmune Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 54. US & Canada Autoimmune Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Autoimmune Drugs Sales by Application (2018-2023) & (K Units)
Table 56. US & Canada Autoimmune Drugs Sales by Application (2024-2029) & (K Units)
Table 57. US & Canada Autoimmune Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 58. US & Canada Autoimmune Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Autoimmune Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Autoimmune Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 61. US & Canada Autoimmune Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Autoimmune Drugs Sales by Country (2018-2023) & (K Units)
Table 63. US & Canada Autoimmune Drugs Sales by Country (2024-2029) & (K Units)
Table 64. Europe Autoimmune Drugs Sales by Type (2018-2023) & (K Units)
Table 65. Europe Autoimmune Drugs Sales by Type (2024-2029) & (K Units)
Table 66. Europe Autoimmune Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Autoimmune Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Autoimmune Drugs Sales by Application (2018-2023) & (K Units)
Table 69. Europe Autoimmune Drugs Sales by Application (2024-2029) & (K Units)
Table 70. Europe Autoimmune Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Autoimmune Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Autoimmune Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Autoimmune Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Autoimmune Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Autoimmune Drugs Sales by Country (2018-2023) & (K Units)
Table 76. Europe Autoimmune Drugs Sales by Country (2024-2029) & (K Units)
Table 77. China Autoimmune Drugs Sales by Type (2018-2023) & (K Units)
Table 78. China Autoimmune Drugs Sales by Type (2024-2029) & (K Units)
Table 79. China Autoimmune Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 80. China Autoimmune Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Autoimmune Drugs Sales by Application (2018-2023) & (K Units)
Table 82. China Autoimmune Drugs Sales by Application (2024-2029) & (K Units)
Table 83. China Autoimmune Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 84. China Autoimmune Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Autoimmune Drugs Sales by Type (2018-2023) & (K Units)
Table 86. Asia Autoimmune Drugs Sales by Type (2024-2029) & (K Units)
Table 87. Asia Autoimmune Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 88. Asia Autoimmune Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Autoimmune Drugs Sales by Application (2018-2023) & (K Units)
Table 90. Asia Autoimmune Drugs Sales by Application (2024-2029) & (K Units)
Table 91. Asia Autoimmune Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 92. Asia Autoimmune Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Autoimmune Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Autoimmune Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 95. Asia Autoimmune Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Autoimmune Drugs Sales by Region (2018-2023) & (K Units)
Table 97. Asia Autoimmune Drugs Sales by Region (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Autoimmune Drugs Sales by Type (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Autoimmune Drugs Sales by Type (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Autoimmune Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Autoimmune Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Autoimmune Drugs Sales by Application (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Autoimmune Drugs Sales by Application (2024-2029) & (K Units)
Table 104. Middle East, Africa and Latin America Autoimmune Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Autoimmune Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Autoimmune Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Autoimmune Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Autoimmune Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Autoimmune Drugs Sales by Country (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America Autoimmune Drugs Sales by Country (2024-2029) & (K Units)
Table 111. Eli Lilly Company Information
Table 112. Eli Lilly Description and Major Businesses
Table 113. Eli Lilly Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 114. Eli Lilly Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Eli Lilly Recent Developments
Table 116. GSK Company Information
Table 117. GSK Description and Major Businesses
Table 118. GSK Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 119. GSK Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. GSK Recent Developments
Table 121. AbbVie Company Information
Table 122. AbbVie Description and Major Businesses
Table 123. AbbVie Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 124. AbbVie Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. AbbVie Recent Developments
Table 126. Johnson & Johnson Company Information
Table 127. Johnson & Johnson Description and Major Businesses
Table 128. Johnson & Johnson Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 129. Johnson & Johnson Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Johnson & Johnson Recent Developments
Table 131. Biogen Company Information
Table 132. Biogen Description and Major Businesses
Table 133. Biogen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 134. Biogen Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Biogen Recent Developments
Table 136. Amgen Company Information
Table 137. Amgen Description and Major Businesses
Table 138. Amgen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 139. Amgen Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Amgen Recent Developments
Table 141. Pfizer Company Information
Table 142. Pfizer Description and Major Businesses
Table 143. Pfizer Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 144. Pfizer Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Pfizer Recent Developments
Table 146. Roche Company Information
Table 147. Roche Description and Major Businesses
Table 148. Roche Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 149. Roche Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Roche Recent Developments
Table 151. Baxter Company Information
Table 152. Baxter Description and Major Businesses
Table 153. Baxter Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 154. Baxter Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Baxter Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Autoimmune Drugs Distributors List
Table 159. Autoimmune Drugs Customers List
Table 160. Autoimmune Drugs Market Trends
Table 161. Autoimmune Drugs Market Drivers
Table 162. Autoimmune Drugs Market Challenges
Table 163. Autoimmune Drugs Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Autoimmune Drugs Product Picture
Figure 2. Global Autoimmune Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Autoimmune Drugs Market Share by Type in 2022 & 2029
Figure 4. Rheumatoid Arthritis (RA) Product Picture
Figure 5. Multiple Sclerosis (MS) Product Picture
Figure 6. Psoriasis Product Picture
Figure 7. Inflammatory Bowel Disease (IBD) Product Picture
Figure 8. Ankylosing Spondylitis (AS) Product Picture
Figure 9. Systemic Lupus Erythematosus (SLE) Product Picture
Figure 10. Global Autoimmune Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Autoimmune Drugs Market Share by Application in 2022 & 2029
Figure 12. Hospitals
Figure 13. Homecare
Figure 14. Specialty Clinics
Figure 15. Autoimmune Drugs Report Years Considered
Figure 16. Global Autoimmune Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Autoimmune Drugs Revenue 2018-2029 (US$ Million)
Figure 18. Global Autoimmune Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Autoimmune Drugs Revenue Market Share by Region (2018-2029)
Figure 20. Global Autoimmune Drugs Sales 2018-2029 ((K Units)
Figure 21. Global Autoimmune Drugs Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Autoimmune Drugs Sales YoY (2018-2029) & (K Units)
Figure 23. US & Canada Autoimmune Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Autoimmune Drugs Sales YoY (2018-2029) & (K Units)
Figure 25. Europe Autoimmune Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Autoimmune Drugs Sales YoY (2018-2029) & (K Units)
Figure 27. China Autoimmune Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Autoimmune Drugs Sales YoY (2018-2029) & (K Units)
Figure 29. Asia (excluding China) Autoimmune Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Autoimmune Drugs Sales YoY (2018-2029) & (K Units)
Figure 31. Middle East, Africa and Latin America Autoimmune Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Autoimmune Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Autoimmune Drugs in the World: Market Share by Autoimmune Drugs Revenue in 2022
Figure 34. Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Autoimmune Drugs Sales Market Share by Type (2018-2029)
Figure 36. Global Autoimmune Drugs Revenue Market Share by Type (2018-2029)
Figure 37. Global Autoimmune Drugs Sales Market Share by Application (2018-2029)
Figure 38. Global Autoimmune Drugs Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Autoimmune Drugs Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Autoimmune Drugs Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Autoimmune Drugs Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Autoimmune Drugs Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Autoimmune Drugs Revenue Share by Country (2018-2029)
Figure 44. US & Canada Autoimmune Drugs Sales Share by Country (2018-2029)
Figure 45. U.S. Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Autoimmune Drugs Sales Market Share by Type (2018-2029)
Figure 48. Europe Autoimmune Drugs Revenue Market Share by Type (2018-2029)
Figure 49. Europe Autoimmune Drugs Sales Market Share by Application (2018-2029)
Figure 50. Europe Autoimmune Drugs Revenue Market Share by Application (2018-2029)
Figure 51. Europe Autoimmune Drugs Revenue Share by Country (2018-2029)
Figure 52. Europe Autoimmune Drugs Sales Share by Country (2018-2029)
Figure 53. Germany Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. France Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 58. China Autoimmune Drugs Sales Market Share by Type (2018-2029)
Figure 59. China Autoimmune Drugs Revenue Market Share by Type (2018-2029)
Figure 60. China Autoimmune Drugs Sales Market Share by Application (2018-2029)
Figure 61. China Autoimmune Drugs Revenue Market Share by Application (2018-2029)
Figure 62. Asia Autoimmune Drugs Sales Market Share by Type (2018-2029)
Figure 63. Asia Autoimmune Drugs Revenue Market Share by Type (2018-2029)
Figure 64. Asia Autoimmune Drugs Sales Market Share by Application (2018-2029)
Figure 65. Asia Autoimmune Drugs Revenue Market Share by Application (2018-2029)
Figure 66. Asia Autoimmune Drugs Revenue Share by Region (2018-2029)
Figure 67. Asia Autoimmune Drugs Sales Share by Region (2018-2029)
Figure 68. Japan Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. South Korea Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. China Taiwan Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. Southeast Asia Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 72. India Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Autoimmune Drugs Sales Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Autoimmune Drugs Revenue Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Autoimmune Drugs Sales Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Autoimmune Drugs Revenue Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Autoimmune Drugs Revenue Share by Country (2018-2029)
Figure 78. Middle East, Africa and Latin America Autoimmune Drugs Sales Share by Country (2018-2029)
Figure 79. Brazil Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Mexico Autoimmune Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. Turkey Autoimmune Drugs Revenue (2018

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Systemic Lupus Erythematosus (Sle) Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Systemic Lupus Erythematosus (Sle) Drugs market: According to our latest research, the global Systemic Lupus Erythematosus (Sle) Drugs market looks promising in the next 5 years. As of 2022, the global Systemic Lupus Erythematosus (Sle) Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......

Autoimmune Drugs Industry Forecasts - China Focus

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 78

This study focuses on China's Autoimmune Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. Th......

Autoimmune Drugs Companies in China

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 71

This study focuses on China's Autoimmune Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of......

Autoimmune Drugs Markets in China

Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 201

China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......

Autoimmune Collaboration and Licensing Deals 2016-2023

Published: 01-Oct-2023        Price: US 3995 Onwards        Pages: 450

Autoimmune Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the autoimmune deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of autoimmune deals from 2016 to 2023. The report includes coverage of the following autoimmune diseases: Multiple sclerosis, Restless leg syndrome, Dermatitis, Eczema, Alopecia, Psoriasis, Celiac disease, Infla......

Global Autoimmune Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 29-Aug-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Autoimmune Drugs market: According to our latest research, the global Autoimmune Drugs market looks promising in the next 5 years. As of 2022, the global Autoimmune Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Autoimmune Drugs market......

Global Autoimmune Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 92

Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental ......

Global Systemic Lupus Erythematosus (SLE) Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 75

SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of ......

Global Systemic Lupus Erythematosus (Sle) Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 11-Jul-2023        Price: US 3260 Onwards        Pages: 130

The Systemic Lupus Erythematosus (Sle) Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Systemic Lupus Erythematosus (Sle) Drugs industry, and breaks down according to the type, application, and consumption area of Systemic Lupus Erythematosus (Sle) Drugs. The report also introduces players in the industry from the per......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs